The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 66, Issue 5, Pages 1444-1453
Publisher
Wiley
Online
2017-06-17
DOI
10.1002/hep.29320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms of HBV-induced hepatocellular carcinoma
- (2016) Massimo Levrero et al. JOURNAL OF HEPATOLOGY
- PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
- (2016) George Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
- (2016) Tung-Hung Su et al. LIVER INTERNATIONAL
- Clinical outcomes after interruption of entecavir therapy in HBeAg-negative chronic hepatitis B patients with compensated cirrhosis
- (2015) Y. C. Chen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
- (2015) W. Ray Kim et al. CANCER
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Optimal management of hepatitis B virus infection – EASL Special Conference
- (2015) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Accuracy of Risk Scores for Patients With Chronic Hepatitis B Receiving Entecavir Treatment
- (2013) Grace Lai–Hung Wong et al. GASTROENTEROLOGY
- Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
- (2013) John Vlachogiannakos WORLD JOURNAL OF GASTROENTEROLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: A propensity score analysis
- (2012) Takashi Kumada et al. JOURNAL OF HEPATOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Transient elastography in chronic viral hepatitis: a critical appraisal
- (2011) A.-C. Cardoso et al. GUT
- Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study
- (2011) G. V. Papatheodoridis et al. GUT
- Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
- (2011) Hwai-I Yang et al. LANCET ONCOLOGY
- Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
- (2010) Vincent Wai-Sun Wong et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review
- (2010) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy
- (2010) E.A. Tsochatzis et al. JOURNAL OF HEPATOLOGY
- Non-invasive assessment of liver fibrosis: are we ready?
- (2010) Laurent Castera et al. LANCET
- Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
- (2008) Man-Fung Yuen et al. JOURNAL OF HEPATOLOGY
- Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
- (2007) George V Papatheodoridis et al. LANCET INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started